Rights and permissions
About this article
Cite this article
Genotype-guided antiplatelet therapy dominant in the US. Pharmacoecon. Outcomes News 650, 3 (2012). https://doi.org/10.2165/00151234-201206500-00010
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201206500-00010